To scan or not to scan, it is a question of timing: technetium-99m-annexin V radionuclide imaging assessment of treatment efficacy after one course of chemotherapy.
To scan or not to scan, it is a question of timing: technetium-99m-annexin V radionuclide imaging assessment of treatment efficacy after one course of chemotherapy.
复制标题
扫描与不扫描，是一个时机问题：锝99m-膜联蛋白V放射性核素显像评估一个疗程化疗后的疗效。
DOI：
--
复制
发表时间：
2002
影响因子：
11.5
通讯作者：
F. Blankenberg
中科院分区：
文献类型：
--
作者：
F. Blankenberg
Belhocine博士和他的团队进行了一项开创性的I期研究，将99mTC-rh-Annexin[2][1]V显像与晚期肺癌和淋巴瘤患者化疗后1-3天内的临床结果相关联[(1)][2]。从这项研究中可以得出的结论是
Doctor Belhocine and his group have conducted a seminal Phase I study correlating 99mTc-rh-annexin[2][1] V imaging with clinical outcome in patients with late-stage lung cancer and lymphoma within 1–3 days after chemotherapy [(1)][2] . The conclusions that can be drawn from this study are quite
DOI：
--
发表时间：
2001-02
期刊：
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子：
--
作者：
F. Blankenberg;Louis Naumovski;Johnathan F. Tait;Anneke M. Post;H. Strauss
通讯作者：
F. Blankenberg;Louis Naumovski;Johnathan F. Tait;Anneke M. Post;H. Strauss